Trial Profile
Incidence and factors associated with deepening of the upper eyelid sulcus (DUES) in Japanese open-angle glaucoma patients who were treated with benzalkonium chloride (BAK)-preserved tafluprost (TAF).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Tafluprost (Primary)
- Indications Open-angle glaucoma
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2015 New trial record